These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 14712233

  • 1. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
    Liu YN, Kang BB, Chen JH.
    Oncogene; 2004 Jan 08; 23(1):278-88. PubMed ID: 14712233
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.
    Wang D, Yamamoto S, Hijiya N, Benveniste EN, Gladson CL.
    Oncogene; 2000 Nov 23; 19(50):5801-9. PubMed ID: 11126367
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S.
    Oncogene; 1998 Sep 24; 17(12):1517-25. PubMed ID: 9794229
    [Abstract] [Full Text] [Related]

  • 4. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
    Renault MA, Jalvy S, Belloc I, Pasquet S, Sena S, Olive M, Desgranges C, Gadeau AP.
    Circ Res; 2003 Oct 03; 93(7):674-81. PubMed ID: 12970113
    [Abstract] [Full Text] [Related]

  • 5. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
    Schultz J, Lorenz P, Ibrahim SM, Kundt G, Gross G, Kunz M.
    Mol Carcinog; 2009 Jan 03; 48(1):14-23. PubMed ID: 18459127
    [Abstract] [Full Text] [Related]

  • 6. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z, Guo H, Wai PY, Gao C, Kuo PC.
    Carcinogenesis; 2006 Jun 03; 27(6):1134-45. PubMed ID: 16474180
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 8. C/EBPalpha is a regulator of the UDP glucuronosyltransferase UGT2B1 gene.
    Hansen AJ, Lee YH, Sterneck E, Gonzalez FJ, Mackenzie PI.
    Mol Pharmacol; 1998 Jun 15; 53(6):1027-33. PubMed ID: 9614204
    [Abstract] [Full Text] [Related]

  • 9. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
    Foka P, Singh NN, Salter RC, Ramji DP.
    Int J Biochem Cell Biol; 2009 May 15; 41(5):1189-97. PubMed ID: 19027873
    [Abstract] [Full Text] [Related]

  • 10. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD.
    Mol Cancer Res; 2005 Oct 15; 3(10):585-96. PubMed ID: 16254192
    [Abstract] [Full Text] [Related]

  • 11. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
    Zhu Y, Denhardt DT, Cao H, Sutphin PD, Koong AC, Giaccia AJ, Le QT.
    Oncogene; 2005 Sep 29; 24(43):6555-63. PubMed ID: 16007184
    [Abstract] [Full Text] [Related]

  • 12. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A, Garwicz D, Lindmark A, Gullberg U.
    Gene; 2005 Aug 15; 356():193-202. PubMed ID: 16019164
    [Abstract] [Full Text] [Related]

  • 13. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
    Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R.
    Physiol Genomics; 2004 Dec 15; 20(1):87-96. PubMed ID: 15479859
    [Abstract] [Full Text] [Related]

  • 14. The role of Osteopontin in tumor metastasis.
    Wai PY, Kuo PC.
    J Surg Res; 2004 Oct 15; 121(2):228-41. PubMed ID: 15501463
    [Abstract] [Full Text] [Related]

  • 15. Trans-activation of heparanase promoter by ETS transcription factors.
    Lu WC, Liu YN, Kang BB, Chen JH.
    Oncogene; 2003 Feb 13; 22(6):919-23. PubMed ID: 12584571
    [Abstract] [Full Text] [Related]

  • 16. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H, Gombart AF, Takeuchi S, Tanaka H, Tanioka M, Matsui H, Kimura A, Inaba T, Koeffler HP.
    Genes Chromosomes Cancer; 2003 Feb 13; 36(2):167-74. PubMed ID: 12508245
    [Abstract] [Full Text] [Related]

  • 17. Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein.
    Zhang J, Yamada O, Matsushita Y, Chagan-Yasutan H, Hattori T.
    Leuk Res; 2010 Jun 13; 34(6):763-8. PubMed ID: 19767100
    [Abstract] [Full Text] [Related]

  • 18. Identification of CCAAT enhancer binding protein alpha binding sites on the human alpha-fetoprotein gene.
    Li HM, Ikeda H, Nakabayashi H, Nishi S, Sakai M.
    Gene; 2007 Mar 15; 389(2):128-35. PubMed ID: 17188819
    [Abstract] [Full Text] [Related]

  • 19. A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line.
    Gao C, Mi Z, Guo H, Wei J, Wai PY, Kuo PC.
    Biochem Biophys Res Commun; 2004 Sep 03; 321(4):1010-6. PubMed ID: 15358129
    [Abstract] [Full Text] [Related]

  • 20. ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha.
    Gombart AF, Grewal J, Koeffler HP.
    J Leukoc Biol; 2007 Jun 03; 81(6):1535-47. PubMed ID: 17347301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.